45985-26-0

Basic information

• Product Name: Piperidinium, 2,2,6,6-tetramethyl-1,4-dioxo-
• CAS NO: 45985-26-0
• Molecular Formula: C9H16NO2
• Molecular Weight: 170.232
• Mol File: 45985-26-0.mol
• Article Data: 66

Chemical Properties

• CAS DataBase Reference: Piperidinium, 2,2,6,6-tetramethyl-1,4-dioxo-(CAS DataBase Reference)
• NIST Chemistry Reference: Piperidinium, 2,2,6,6-tetramethyl-1,4-dioxo-(45985-26-0)
• EPA Substance Registry System: Piperidinium, 2,2,6,6-tetramethyl-1,4-dioxo-(45985-26-0)

Safety Data

• Hazardous Substances Data: 45985-26-0(Hazardous Substances Data)

Upstream product

• 137003-52-2 <15N>-2,2,6,6-tetramethyl-4-piperidone 
• 22963-71-9 1-hydroxy-4-oxo-2,2,6,6-tetramethylpiperidine hydrochloride 
• 2403-88-5 4-hydroxy-2,2,6,6-tetramethylpiperidine 
• 95407-69-5 4-methoxy-2,2,6,6-tetramethylpiperidin-1-oxyl radical 
• 37149-18-1 1-oxyl-4-carboxyl-2,2,6,6-tetramethylpiperidine 
• 45985-24-8 TEMPOL 
• 32889-28-4 2,2,6,6-Tetramethyl-4-oxo-1-hydroxypiperidinium-perchlorat 
• 3637-11-4 1-hydroxy-2,2,6,6-tetramethyl-piperidin-4-one 
• 2564-83-2 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical 
• 826-36-8 2,2,6,6-Tetramethyl-4-piperidone 
• 122586-81-6 2,2,6,6-tetramethyl-1-(1-phenylethoxy)-4-piperidinone 
• 42391-54-8 2-<4-chlorophenyl>-4,6-diphenylverdazyl 
• 122-66-7 diphenyl hydrazine 
• 33973-59-0 2,2,6,6-tetramethylpiperidin-4-one hydrochloride 

Downstream Products

• 3637-11-4 1-hydroxy-2,2,6,6-tetramethyl-piperidin-4-one 
• 1227476-15-4 Azobenzene 
• 77874-89-6 2,2,6,6-tetramethyl-3-methoxycarbonyl-4-piperidone-1-oxyl 
• 2564-83-2 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical 
• 95407-69-5 4-methoxy-2,2,6,6-tetramethylpiperidin-1-oxyl radical 
• 38078-71-6 4-cyano-2,2,6,6-tetramethyl-piperidinyloxy 
• 37149-18-1 1-oxyl-4-carboxyl-2,2,6,6-tetramethylpiperidine 
• 22963-71-9 1-hydroxy-4-oxo-2,2,6,6-tetramethylpiperidine hydrochloride 
• 42249-40-1 C₁₆H₂₈N₃O 
• 122586-79-2 1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-one 
• 137063-53-7 2',3'-O-(1-acetoxy-2,2,6,6-tetramethyl-4-piperidylidene)-5'-O-benzoyluridine 
• 104725-64-6 C₁₆H₂₃N₂O₅ 

Relevant articles and documents

Ultrathin 2D Zirconium Metal–Organic Framework Nanosheets: Preparation and Application in Photocatalysis

Synthesizing ultrathin 2D metal–organic framework nanosheets in high yields has received increasing research interest but remains a great challenge. In this work, ultrathin zirconium-porphyrinic metal–organic framework (MOF) nanosheets with thickness down to ≈1.5 nm are synthesized through a pseudoassembly–disassembly strategy. Owing to the their unique properties originating from their ultrathin thickness and highly exposed active sites, the as-prepared ultrathin nanosheets exhibit far superior photocatalysis performance compared to the corresponding bulk MOF. This work highlights new opportunities in designing ultrathin MOF nanosheets and paves the way to expand the potential applications of MOFs.

Spin-labeled naphthalimide oxygen-containing compound and application thereof

The invention belongs to the technical field of medical drugs, and relates to a spin-labeled naphthalimide compound containing an oxygen substituent and an application thereof, in particular to a stable nitroxide free radical labeled naphthalimide compound containing an oxygen substituent and an application thereof in preparation of anti-tumor drugs. According to the spin-labeled naphthalimide oxygen-containing compound and the application thereof, a stable nitroxide free radical is introduced into an oxygen-containing substituent naphthalimide parent to obtain the naphthalimide compound shown in the general formula I and pharmaceutically acceptable salt thereof, and the compound has good anti-tumor activity, shows lower toxicity to normal cells than a naphthalimide analogue containing a nitrogen substituent, and has very good development and application prospects.

A class of stable nitroxide free radical modified naphthalimide compounds, and application thereof

The invention belongs to the technical field of medicines, and relates to a class of naphthalimide compounds modified by stable nitroxide free radicals, and application thereof, particularly to a class of naphthalimide compounds with stable nitroxide free radicals, and application of the naphthalimide compounds in preparation of antitumor medicines. According to the invention, stable nitroxide free radicals are introduced into a naphthalimide parent structure to obtain a naphthalimide compound represented by a general formula I or II, and a pharmaceutically acceptable salt, a solvate and a hydrate thereof, wherein R1, R2, R3 and R4 are defined in the claims and the specification.